Short Survey
Genetics of rheumatoid arthritis: A new boost is needed in Latin American populations
Fecha
2016Registro en:
56, 2, 171-177
04825004
Autor
Castro-Santos P.
Díaz-Peña R.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Genomics, proteomics and metabolomics: Their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers
Castro-Santos P.; Laborde C.M.; Díaz-Peña R. (Clinical and Experimental Rheumatology S.A.S., 2015) -
The role of protein SUMOylation in rheumatoid arthritis
Dehnavi S.; Sadeghi M.; Johnston T.P.; Barreto G.; Shohan M.; Sahebkar A. (Academic Press, 2019) -
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: The GO-FORWARD Study
Keystone, E. C.; Genovese, M. C.; Klareskog, L.; Hsia, E. C.; Hall, S. T.; Miranda, P. C.; Pazdur, J.; Bae, S. C.; Palmer, W.; Zrubek, J.; Wiekowski, M.; Visvanathan, S.; Wu, Z.; Rahman, M. U. (2009)Objective: The phase III GO-FORWARD study examined the efficacy and safety of golimumab in patients with active rheumatoid arthritis (RA) despite methotrexate therapy. Methods: Patients were randomly assigned in a 3 : 3 : ...